{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:46:41Z","timestamp":1794642401151,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>\n                    Mesonephric-like adenocarcinoma (MLA) was introduced as a new tumor type in the endometrium and the ovary in the 2020 World Health Organization (WHO) Classification. This is a rare recently described (2016) and clinically aggressive carcinoma with a propensity for distant spread, especially to the lungs. MLA has a characteristic morphology and immunophenotype (hormone receptor negative; TTF1 and\/or GATA3 positive). These neoplasms are commonly associated with\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    mutations and in the Cancer Genome Atlas (TCGA) molecular classification of endometrial carcinomas fall into the copy number low\/no specific molecular profile category. Although they show significant morphological, immunophenotypic and molecular overlap with cervical mesonephric adenocarcinomas, there are other parameters which suggest a Mullerian origin and, as such, the term MLA seems apt. MLA can be added to the list of endometriosis-associated ovarian neoplasms. In this paper, I outline the series of events which lead to the first description of MLA and review the subsequent literature on this tumor type which has expanded on the morphologic features and immunophenotype, discovered the molecular underpinnings and elucidated the clinical behavior. The discovery of MLA represents an example of \u201cnew\u201d entities still to this day being discovered through careful morphologic observations and referral of cases for specialist opinion.\n                  <\/jats:p>","DOI":"10.1097\/pap.0000000000000342","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T12:01:13Z","timestamp":1649246473000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":55,"title":["Mesonephric-like Adenocarcinoma of the Female Genital Tract: From Morphologic Observations to a Well-characterized Carcinoma With Aggressive Clinical Behavior"],"prefix":"10.1097","volume":"29","author":[{"given":"W. Glenn","family":"McCluggage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/jcm10040698","article-title":"Mesonephric-like adenocarcinoma of the endometrium: diagnostic advances to spot this wolf in sheep\u2019s clothing. A review of the literature","volume":"10","author":"Deolet","year":"2021","journal-title":"J Clin Med"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PGP.0000000000000573","article-title":"Ovarian combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a Mullerian origin of mesonephric-like adenocarcinoma","volume":"39","author":"McCluggage","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","article-title":"An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a M\u00fcllerian origin for some mesonephric carcinomas","volume":"37","author":"Chapel","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-020-01012-z","article-title":"Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis","volume":"15","author":"Dundr","year":"2020","journal-title":"Diagn Pathol"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PAS.0000000000001766","article-title":"Extrauterine mesonephric-like neoplasms: expanding the morphologic spectrum","volume":"46","author":"Deolet","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAS.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior","volume":"44","author":"Euscher","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","article-title":"Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multi-institutional study","volume":"45","author":"Pors","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-019-0830-4","article-title":"Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a M\u00fcllerian duct lineage: a case report","volume":"14","author":"Yano","year":"2019","journal-title":"Diagn Pathol"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium","volume":"43","author":"Kolin","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PGP.0000000000000781","article-title":"Endometrial mesonephric-like adenocarcinoma presenting as an ocular lesion: a case report","volume":"41","author":"Al Nabhani","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.21873\/anticanres.15053","article-title":"Dedifferentiated mesonephric-like adenocarcinoma of the uterine corpus","volume":"41","author":"Choi","year":"2021","journal-title":"Anticancer Res"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","article-title":"Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma","volume":"146","author":"Horn","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.humpath.2018.08.018","article-title":"Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma","volume":"86","author":"Patel","year":"2019","journal-title":"Hum Pathol"},{"key":"R15-20250615","article-title":"Two cases of mesonephric-like carcinoma arising from endometriosis: case report and review of the literature","author":"Chang","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pathol.2017.11.084","article-title":"Mesonephric proliferations of the female genital tract","volume":"50","author":"Howitt","year":"2018","journal-title":"Pathology"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200405000-00006","article-title":"Malignant mesonephric tumors of the female genital tract. A clinicopathologic study of 9 cases","volume":"28","author":"Bague","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200103000-00013","article-title":"Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings","volume":"25","author":"Silver","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-\u03b2","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/PAS.0000000000000476","article-title":"Morphologic and molecular characteristics of mixed epithelial ovarian cancers","volume":"39","author":"Mackenzie","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.2003.01684.x","article-title":"CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma","volume":"43","author":"McCluggage","year":"2003","journal-title":"Histopathology"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000478-200302000-00005","article-title":"CD10 expression in epithelial tissues and tumors of the gynecologic tract","volume":"27","author":"Ordi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R29-20250615","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"R30-20250615","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","volume":"34","author":"da Silva","year":"2021","journal-title":"Mod Pathol"},{"key":"R31-20250615","first-page":"37","article-title":"Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma","volume":"8","author":"Shen","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R33-20250615","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/his.13970","article-title":"Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions","volume":"76","author":"McCluggage","year":"2020","journal-title":"Histopathology"},{"key":"R34-20250615","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e3181131e21","article-title":"Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas","volume":"31","author":"Siami","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/modpathol.2008.4","article-title":"Thyroid transcription factor-1 expression in ovarian epithelial neoplasms","volume":"21","author":"Kubba","year":"2008","journal-title":"Mod Pathol"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/PAS.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/00000478-199512000-00001","article-title":"Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. A report of 14 cases","volume":"19","author":"Tornos","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/PGP.0000000000000222","article-title":"Value of PAX-8 and SF-1 immunohistochemistry in the distinction between female adnexal tumor of probable Wolffian origin and its mimics","volume":"35","author":"Goyal","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R39-20250615","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/PAS.0000000000001677","article-title":"A distinctive adnexal (usually paratubal) neoplasm often associated with Peutz-Jeghers syndrome and characterized by STK11 alterations (STK11 adnexal tumor): a report of 22 cases","volume":"45","author":"Bennett","year":"2021","journal-title":"Am J Surg Pathol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:02:24Z","timestamp":1750003344000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000342","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,7]]}}}